Editorial: Metabolic supplementation with orotic acid and magnesium orotate

Cardiovascular Drugs and Therapy

Volumn 12, Issue SUPPL. 2, 1998, Pages 147-152

  Rosenfeldt, Franklin L ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiomyopathy; Heart; Metabolism; Orotic; Orotic acid

Indexed keywords

OROTATE MAGNESIUM; OROTIC ACID; PURINE; PYRIMIDINE; PYRIMIDINE DERIVATIVE; URIDINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHLETE; BIOSYNTHESIS; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENERGY; EXERCISE; EXERCISE TOLERANCE; HAMSTER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; SYMPOSIUM; TISSUE LEVEL; ANIMAL; CONFERENCE PAPER; HEART MUSCLE; METABOLISM;

ANIMALS; CORONARY DISEASE; HUMANS; MYOCARDIUM; OROTIC ACID;

EID: 0031661865     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007732131887     Document Type: Article

References (25)

1. Rundles RW, Brewer SS. Haematologic responses in pernicious anemia to orotic acid. Blood 1958;13:99-115.
2. Schwarze R, Kintzel, HW, Hinkel GK. The influence of orotic acid on the serum bilirubin level of mature newborn. Acta Paediatr Scand 1971;60:705-708.
3. Pavesio D, Pecco P, Imdicello P. Fructose-induced hyperuricaemia and its compensation by the healthy infant. Minerva Pediatr 1972;24:125-132.
4. Windmueller HG, Levy RI. Total inhibition of hepatic betalipoprotein production in the rat by orotic acid. J Biol Chem 1967;242:2246-2254.
5. Meerson FZ. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 1969;24/25(Suppl. 2): II146-II155.
6. Meerson FZ, Rosanova LS. Effect of 2703 actinomycin and combination of nucleic acid synthesis activators on the development of fatigue and fitness. Dokl Akad Nauk SSSR 1967;166:496-499.
7. Simonson E, Berman R. New approach in treatment of cardiac decompensation in USSR. Am Heart J 1973;86:117-123.
8. Chazov E, personal communication, 1995.
9. Williams JF, Donohoe J, Lykke A, Kolos G. Studies using orotic acid for improving the controlled development of myocardial hypertrophy. Aust N Z J Med 1976;6(Suppl. 2):60-71.
10. Donohoe JA, Williams JF, Kolos G, Hickie JB. The action of orotic acid as a positive inotropic agent during the acute phase of myocardial hypertrophy. Aust N Z J Med 1974; 4:542-548.
11. Donohoe JA. The Role of Orotic Acid in the Acutely Stressed Myocardium. PhD Thesis. Australian National University, 1977.
12. Donohoe JA, Rosenfeldt FL, Munsch CM, Williams JF. The effect of orotic acid treatment on the energy and carbohydrate metabolism of the hypertrophying rat heart. Int J Biochem 1993;25:163-182.
13. Newman MAJ, Chen X-Z, Rabinov M, Williams JF, Rosenfeldt FL. Sensitivity of the recently infarcted heart to cardioplegic arrest. J Thorac Cardiovasc Surg 1989;97: 593-604.
14. Munsch C, Williams JF, Rosenfeldt FL. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: The protective effect of orotic acid. J Mol Cell Cardiol 1989;21:751-754.
15. Munsch CM, Rosenfeldt FL, O'Halloran K, Langley LH, Conyers RAJ, Williams JF. The effect of orotic acid on the response of the recently infarcted rat heart to hypothermic cardioplegia. Eur J Cardiothorac Surg 1991;5:92-93.
16. Munsch CM, Williams JF, Conyers RAJ, O'Halloran K, Langley LH, Rosenfeldt FL. The effect of orotic acid and ribose on the impaired tolerance of the recently infarcted rat heart to cardioplegic arrest. In: Williams JF, ed. Orotic Acid in Cardiology. New York:Thieme Medical, 1992:46-58.
17. Cochrane AD, Pathik S, Smolich JJ, Conyers RAJ, Rosenfeldt FL. Depressed function in non-infarcted myocardium after recent myocardial infarction: Influence of orotic acid. Ann Thorac Surg 1996;62:1765-1772.
18. Bailey LE. Orotic acid prevents changes in cardiac sarcolemmal glycoproteins and contractility associated with muscular dystrophy in hamsters. Experientia 1980;36:6-7.
19. Bajusz E, Baker JR, Nixon CW, Homburger F. Spontaneous, hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann NY Acad Sci 1969;156:105-129.
20. Zimmer H-G. Effects of magnesium orotate on rat heart function. Cardioscience 1994;5:55-61.
21. Bajusz E, Homburger F, Baker JR, Bogdonoff P. Dissociation of factors influencing myocardial degeneration and generalized cardiocirculatory failure. Ann NY Acad Sci 1969; 156:396-420.
22. Golf S, Happel O, Graef V. Plasma aldosterone, cortisol and electrolyte concentrations in physical exercise after magnesium supplementation. J Clin Chem Clin Biochem 1984;22: 717-721.
23. Yeh T Jr., Rebeyka IM, Jakoi ER, Johnson DE, Dignan RJ, Dyke CM, Weschler AS. Orotic acid improves left ventricular recovery four days after heterotopic transplantation. Ann Thorac Surg 1994;58:409-415.
24. Zimmer H-G, Schneider A. Nucleotide precursors modify the effects of isoproterenol. Studies on heart function and cardiac adenine nucleotide content in intact rats. Circ Res 1991;69:1575-1582.
25. Oldfield GS, Commerford PJ, Opie LH. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thorac Cardiovasc Surg 1986;91:874-878.